Buy MOUNJARO®
Showing all 8 results
-


MOUNJARO® 10mg KwikPen®, 1 Stk. (English Alterna...
$ 539.00 Read More-+

MOUNJARO® 12.5mg KwikPen®, 1 Stk.
$ 579.00 Read More-+

MOUNJARO® 15mg KwikPen®, 1 Stk.
$ 599.00 Read More-+

MOUNJARO® 2.5mg KwikPen®, 1 Stk. (English Altern...
$ 469.00 Read More-+

MOUNJARO® 5mg KwikPen®, 1 Stk.
$ 499.00 Read More-+

MOUNJARO® 5mg KwikPen®, 1 Stk. (English Alternat...
$ 499.00 Read More-+

MOUNJARO® 7.5mg KwikPen®, 1 Stk.
$ 519.00 Read More-+

MOUNJARO® 7.5mg KwikPen®, 1 Stk. (English Altern...
$ 519.00 Read More-+What MOUNJARO® Is Used For
MOUNJARO® is prescribed for adults with type 2 diabetes mellitus who need additional support in managing blood sugar. It is also used for weight management when combined with diet and physical activity. Treatment is recommended for individuals with a Body Mass Index (BMI) ≥30 kg/m², or those with a BMI ≥27 kg/m² who also have weight-related conditions such as hypertension, cardiovascular disease, or sleep apnoea.
-
Helps improve glycaemic control in type 2 diabetes.
-
Supports weight loss and maintenance in adults with obesity or overweight.
-
Works best alongside healthy eating and regular exercise.
-
Suitable as monotherapy or in combination with other diabetes medications.
What Makes MOUNJARO® a Good Choice
MOUNJARO® offers a flexible, once-weekly treatment that supports both blood sugar control and weight loss. Its stepwise dosing reduces the risk of side effects while ensuring effectiveness.
-
Once-weekly injection for convenience.
-
Can be combined with oral antidiabetic medicines or insulin.
-
Available in a range of doses, allowing gradual escalation.
-
Shown in trials to reduce HbA1c and body weight.
Different MOUNJARO® Products
MOUNJARO® comes in multiple strengths, making it easier to tailor treatment. Each KwikPen® contains four doses.
-
2.5 mg/dose KwikPen® (starter dose, 4 doses per pen).
-
5 mg/dose KwikPen® (maintenance option, 4 doses per pen).
-
7.5 mg/dose KwikPen® (step-up option, 4 doses per pen).
-
10 mg/dose KwikPen® (commonly used maintenance, 4 doses per pen).
-
12.5 mg/dose KwikPen® (intermediate step, 4 doses per pen).
-
15 mg/dose KwikPen® (maximum dose, 4 doses per pen).
Best Uses and Target Areas
MOUNJARO® is not a first-line treatment but is valuable when other methods are not enough. It is effective for both metabolic control and long-term weight reduction.
-
Diabetes control: Helps patients reach blood glucose targets.
-
Obesity management: Supports sustained weight loss.
-
Overweight patients with comorbidities: Recommended when extra risk factors exist.
-
Flexible treatment: Can be used alone or with other diabetes medicines.
Key Ingredients in MOUNJARO®
The main component is tirzepatide, a dual GIP and GLP-1 receptor agonist. It is combined with excipients that stabilize the solution.
-
Tirzepatide: Active substance, available in multiple strengths.
-
Excipients: Includes benzyl alcohol (5.4 mg per 0.6 mL dose), glycerol, phenol, sodium chloride, sodium hydroxide, hydrochloric acid, and water for injections.
-
Sodium content: Less than 1 mmol per dose (sodium-free).
-
Appearance: Clear, colourless to slightly yellow solution.
How It’s Given (Injection Guide for MOUNJARO®)
MOUNJARO® is delivered by subcutaneous injection once per week. Patients can self-administer after proper training.
-
Injection sites: Abdomen, thigh, or upper arm.
-
Dosing schedule:
-
Start with 2.5 mg weekly for 4 weeks.
-
Increase in 2.5 mg steps every ≥4 weeks until desired dose.
-
Maximum dose: 15 mg weekly.
-
-
Missed dose:
-
If within 4 days, take it as soon as possible.
-
If more than 4 days, skip and continue with next dose.
-
-
Rotate injection sites to prevent irritation.
Storage and Expiry Details
Proper storage is essential to maintain product quality.
-
Unopened pens: Refrigerate at 2–8 °C.
-
Do not freeze; discard if frozen.
-
After first use: May be stored at ≤30 °C for 30 days.
-
Discard after 30 days, even if solution remains.
-
Keep out of reach of children.
Possible Side Effects to Know
Like all medicines, MOUNJARO® may cause side effects, most often affecting the digestive system. These usually occur early in treatment and lessen over time.
-
Very common: Nausea, diarrhoea, vomiting, constipation, abdominal pain.
-
Common: Decreased appetite, dyspepsia, dizziness, fatigue, mild injection-site reactions.
-
Occasional: Gallbladder issues (e.g., cholelithiasis, cholecystitis).
-
Rare: Acute pancreatitis, severe allergic reactions (anaphylaxis, angioedema).
-
Laboratory changes: Elevated amylase and lipase levels.
Quick Answers About MOUNJARO®
-
How often is it taken? Once weekly.
-
Does it replace insulin? No, but it can be used alongside insulin with dose adjustment.
-
Who should avoid it? Those with hypersensitivity to tirzepatide or severe gastrointestinal disease.
-
What if I’m pregnant or breastfeeding? It is not recommended during pregnancy or lactation.
-
Is it safe long-term? Clinical studies show ongoing effectiveness, but monitoring is required.
Where to Buy MOUNJARO®
Healthcare professionals and clinics can buy MOUNJARO® online or through verified distributors. Contact the sales representatives on Direct Doctor Supply
Content prepared by Direct Doctor Supply’s editorial team.
Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.


